loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 212619 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AMPHETAMINE SULFATE (2)

filter

01 GRANULES (2)

filter

01 TABLET;ORAL (2)

filter

01 10MG (1)

02 5MG (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
10MG
AMPHETAMINE SULFATE
USA
212619
2019-08-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
5MG
AMPHETAMINE SULFATE
USA
212619
2019-08-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 212619

Looking for CTD TGA MCC DOSSIER APPLICATION 212619 2

19

Granules India Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.

One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 212619 and regulatory information .

proudly manufactured in the

approval since 2019-08-05

Granules India Limited's AMPHETAMINE SULFATE TABLET;ORAL, medication with 10MG of AMPHETAMINE SULFATE.

18

Granules India Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.

One of their notable products is AMPHETAMINE SULFATE, with a corresponding application number 212619 and regulatory information .

proudly manufactured in the

approval since 2019-08-05

Granules India Limited's AMPHETAMINE SULFATE TABLET;ORAL, medication with 5MG of AMPHETAMINE SULFATE.

Post Enquiry
POST ENQUIRY